Tag: SD

Blue Horseshoe Stocks: BIND Recap & More

BIND Therapeutics, Inc. BIND

BIND cropped up on our premarket scanner yesterday in the wake of a post-market PR on Wednesday afternoon, and it put forth a solid move early in the session. It traded as low as 7.40 at the open, and we then witnessed a significant 36% spike to the high-of-day at 10.04.

That initial run was fueled by the release of positive Phase-2 results from one of the company’s many cancer treatments currently in various trial phases, and additionally, an update on guidance for 2015.  >>> READ PR

According to the CEO, BIND expects 2015 “to be a particularly active period” with regard to the development of its many products, so this will be a play that we’ll want to monitor more closely moving forward.

Toward the end of the session yesterday BIND pulled back, and is gapping once again in the pre-market, so we have our eyes peeled for any potential bounce action that could be used in our favor.

Twitter, Inc. TWTR – Options

We’ve also got to update everyone on the options trading idea we put forth earlier this week for TWTR. We mentioned an interest in the Weekly $38 and $39 Calls, and each set of contracts showed us a huge spike during yesterday’s session.

The $38’s traded in a range from .23-1.22, for a chance at monstrous gains of up to 430%, while the $39’s did even better as they ripped from .09 to a high of .54, a move totaling 500%

We also wanted to remind readers of the long-term options idea for TWTR we mentioned in the same report. The February $40 Calls could be in line for significant gains if TWTR continues to recover off of recent lows in the $35-36 range.

Extended Watchlist:
AGEN, CERE, ARNA, SD, NVAX, CARA

ARO, RMTI, PHOT & Extended Watchlist

Aeropostale, Inc. ARO

At the beginning of August, ARO began to experience a substantial sell-off that would cause the stock to fall from the $15-range to less than $8 at the beginning of this month. We are standing at the ready this morning as we’ve observed some northward pre-market trading, with shares changing hands for as much as 10.13. The significant gaps on the chart being filled could provide not only opportunities on the stock side of things, but in the trading of options contracts as well.

The 10/19 $9.00 Calls are of particular interest to us; Closing at .35 yesterday, and with this morning’s gap-up activity, these calls could open up as much as 100%  In that event, we would be looking for a consolidation before getting our feet wet.

Rockwell Medical, Inc. RMTI

RMTI would make a nice intraday move for us after its appearance in yesterday’s morning report, running from a low of 8.75 and reaching its peak at 11.80, good enough for a 35% gain.

Following the high, the stock came back as low as 9.85. Moving we are looking for the stock to hold support at its previous swing low of 8.75. In the meantime the company released an encouraging PR today announcing the completion of an important step in getting a new kidney drug to market, that appears to be contributing to yet another gap-up situation today.

WIXOM, MI–(Marketwired – Sep 17, 2013) – Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, today announced the U.S. Food & Drug Administration (FDA) accepted the proposed proprietary trade name Triferic™ for the Company’s investigational iron-delivery drug, previously known as Soluble Ferric Pyrophosphate (SFP), which is intended for treating iron deficiency in chronic kidney disease patients receiving hemodialysis. A request for proprietary name review for Triferic™ will be filed with the New Drug Application (NDA) submission.>>>FULL STORY

GroLife, Inc. PHOT

We had another gainer in PHOT yesterday, as the stock jumped from .046 to .061, affording us the opportunity at a 33% intraday rip. Since 08/30 when we re-mentioned PHOT, it has been as low as .0318, which makes yesterday’s high a move of 93%

For almost a year now, we’ve placed a strong focus on marijuana-related stocks, publishing several reports, and doing the most recent followup at the end of August. The industry has, and we believe, will continue to bring us profits in the future. It’s for that reason we suggest everyone keep a marijuana stock watchlist of their own. We have only just begun to realize the potential for this up-and-coming sector, which is certain to be a high-growth area for years to come.

Extended Watchlist:
AGEN, NBS, BCRX, RGDO, SUTR, DNDN, MATR, SD